Follow
Janette Bester
Janette Bester
Senior lecturer at University of Pretoria
Verified email at up.ac.za
Title
Cited by
Cited by
Year
The dormant blood microbiome in chronic, inflammatory diseases
M Potgieter, J Bester, DB Kell, E Pretorius
FEMS microbiology reviews 39 (4), 567-591, 2015
4412015
Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
J Bester, E Pretorius
Scientific reports 6 (1), 32188, 2016
3302016
A comprehensive review on eryptosis
E Pretorius, JN du Plooy, J Bester
Cellular Physiology and Biochemistry 39 (5), 1977-2000, 2016
2062016
The inflammatory effects of TNF-α and complement component 3 on coagulation
MJ Page, J Bester, E Pretorius
Scientific reports 8 (1), 1812, 2018
1362018
Erythrocytes and their role as health indicator: Using structure in a patient-orientated precision medicine approach
E Pretorius, O Oore-ofe, S Mbotwe, J Bester
Blood reviews 30 (4), 263-274, 2016
1062016
Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications …
E Pretorius, J Bester, N Vermeulen, S Alummoottil, P Soma, AV Buys, ...
Cardiovascular diabetology 14, 1-20, 2015
982015
Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide
E Pretorius, S Mbotwe, J Bester, CJ Robinson, DB Kell
Journal of the Royal Society interface 13 (122), 20160539, 2016
962016
Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)
J Bester, P Soma, DB Kell, E Pretorius
Oncotarget 6 (34), 35284, 2015
862015
Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
J Bester, C Matshailwe, E Pretorius
Cytokine 110, 237-242, 2018
842018
High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease
J Bester, AV Buys, B Lipinski, DB Kell, E Pretorius
Frontiers in aging neuroscience 5, 88, 2013
752013
Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and …
E Pretorius, J Bester, N Vermeulen, B Lipinski, GS Gericke, DB Kell
PloS one 9 (1), e85271, 2014
742014
Oxidation inhibits iron-induced blood coagulation
E Pretorius, J Bester, N Vermeulen, B Lipinski
Current drug targets 14 (1), 13-19, 2013
692013
A bacterial component to Alzheimer’s-type dementia seen via a systems biology approach that links iron dysregulation and inflammagen shedding to disease
E Pretorius, J Bester, DB Kell
Journal of Alzheimer's Disease 53 (4), 1237-1256, 2016
652016
A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy
E Pretorius, N Vermeulen, J Bester, B Lipinski, DB Kell
Toxicology mechanisms and methods 23 (5), 352-359, 2013
652013
Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice
E Pretorius, AC Swanepoel, S DeVilliers, J Bester
Thrombosis research 154, 59-63, 2017
492017
The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia
E Pretorius, J Bester, MJ Page, DB Kell
Frontiers in aging neuroscience 10, 257, 2018
432018
Novel diagnostic and monitoring tools in stroke: an individualized patient-centered precision medicine approach
S De Villiers, A Swanepoel, J Bester, E Pretorius
Journal of atherosclerosis and thrombosis 23 (5), 493-504, 2016
362016
Interleukin‐12 and its procoagulant effect on erythrocytes, platelets and fibrin (ogen): the lesser known side of inflammation
MJ Page, J Bester, E Pretorius
British journal of haematology 180 (1), 110-117, 2018
312018
Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes
E Pretorius, B Lipinski, J Bester, N Vermeulen, P Soma
Ultrastructural pathology 37 (4), 254-257, 2013
292013
Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach
E Pretorius, J Bester
Oncotarget 7 (32), 50895, 2016
252016
The system can't perform the operation now. Try again later.
Articles 1–20